All stock lists
Unlock the score
Harvard Apparatus Regenerative Technology, Inc. (OTC:HRGN)
US · Delayed Price · Currency is USD
Also listed: BSTGHealthcare · Biotechnology
1.97+0.00 (+0.00%)
Insider Score
/ 100
HRGN Insider Score
Harvard Apparatus Regenerative Technology, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
HRGN Stock Insider Trading Activity
HRGN stock’s insider trading shows 2 purchases for an estimated $394.46K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days2 qualifying buys1 insider$394.46K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| He Junli CEO | Buy | 6,725 | $2.15 | $14.46K | 0.5% | 1,332,930 | Sep 15, 2026 | CCEO Buy | Form 4 |
| He Junli CEO | Converted | 683,725 | $1.05 | $717.91K | 244% | 964,300 | Sep 11, 2026 | — | Form 4 |
| He Junli CEO | Buy | 361,905 | $1.05 | $380.00K | 37.5% | 1,326,205 | Sep 11, 2026 | BCEO Buy | Form 4 |
| He Junli CEO | Buy | 3,000 | $1.70 | $5.10K | 1.1% | 280,575 | Nov 25, 2025 | CCEO Buy | Form 4 |
| He Junli CEO | Buy | 300 | $1.98 | $594 | 0.1% | 277,575 | Sep 30, 2025 | CFirst BuyCEO Buy | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Converted (C) — Conversion of a derivative security into shares
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.